Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee

Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee

Item
http://www.wikidata.org/entity/Q34056295
Taking a Measured Approach to Toxicity Data in Phase I Oncology Clinical Trials.A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511).Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee.Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and CilengitideA phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors.The changing landscape of phase I trials in oncology.Mechanisms of Therapeutic Resistance in Prostate Cancer.A two-dimensional biased coin design for dual-agent dose-finding trials.From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely.Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC.A synthetic combinatorial approach to disabling deviant Hedgehog signaling.Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology.
P2860

Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee

Item
http://www.wikidata.org/entity/Q34056295
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Design of phase I combination ...... tional Drug Steering Committee
@ast
Design of phase I combination ...... tional Drug Steering Committee
@en
Design of phase I combination ...... tional Drug Steering Committee
@nl
type
label
Design of phase I combination ...... tional Drug Steering Committee
@ast
Design of phase I combination ...... tional Drug Steering Committee
@en
Design of phase I combination ...... tional Drug Steering Committee
@nl
prefLabel
Design of phase I combination ...... tional Drug Steering Committee
@ast
Design of phase I combination ...... tional Drug Steering Committee
@en
Design of phase I combination ...... tional Drug Steering Committee
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Design of phase I combination ...... tional Drug Steering Committee
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-14-0521
P407
P433
P478
P50
P577
P5875
P698
P921
P932